Phosphatidic Acid
Mechanism of Action +
### Introduction to Lipid Second Messengers Phosphatidic acid (PA) is a diacylglycerol lipid containing a phosphate group, making it a fundamental constituent of cell membranes and a critical lipid second messenger in cellular signaling. While it is naturally found in very small concentrations in muscle tissue, its biosynthesis in the body and presence in whole foods is highly limited. In the context of skeletal muscle physiology, PA serves as a central signaling molecule that translates mechanical stimuli into biochemical signals, ultimately driving muscle hypertrophy.
### Phospholipase D (PLD) and Endogenous PA Synthesis Under normal physiological conditions, mechanical loading—such as the stress induced by resistance exercise—activates the enzyme phospholipase D (PLD). PLD hydrolyzes phosphatidylcholine, a common membrane phospholipid, yielding choline and endogenous phosphatidic acid. This localized spike in intracellular PA concentration is a critical step in the mechanotransduction pathway. However, relying solely on endogenous PLD activation limits the maximal anabolic response. Exogenous supplementation with oral PA, specifically the patented Mediator® 50P compound, bypasses the rate-limiting step of PLD activation, artificially elevating intracellular PA levels to maximize anabolic signaling.
### The Mechanistic Target of Rapamycin (mTOR) Complex 1 The mechanistic target of rapamycin (mTOR) is a highly conserved serine/threonine kinase that functions as the master regulator of cell growth, proliferation, and survival. In skeletal muscle, mTOR exists primarily in two distinct multi-protein complexes: mTORC1 and mTORC2. mTORC1 is the complex directly responsible for regulating muscle protein synthesis (MPS) in response to nutrients, energy status, and mechanical stress. Activation of mTORC1 is the definitive biochemical trigger for load-induced skeletal muscle growth.
### PA Binding to the FRB Domain of mTOR Phosphatidic acid exerts its anabolic effects through direct physical interaction with mTORC1. Biochemical assays have demonstrated that PA binds specifically to the FKBP12-rapamycin binding (FRB) domain of mTOR. This binding event is believed to induce a conformational change in the mTOR complex, displacing endogenous inhibitory proteins (such as DEPTOR) and facilitating the assembly and activation of the complete mTORC1 complex. Unlike amino acids (such as leucine), which activate mTORC1 via the Rag GTPase pathway, PA activates mTORC1 through this distinct, direct binding mechanism. This allows for synergistic activation when PA and amino acids are present simultaneously.
### Downstream Effectors: p70S6K and 4E-BP1 Once activated by PA, mTORC1 phosphorylates several key downstream targets that initiate translation and muscle protein synthesis. The two most prominent targets are the 70-kDa ribosomal protein S6 kinase (p70S6K) and the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Phosphorylation of p70S6K leads to the activation of ribosomal protein S6, which promotes the translation of mRNAs encoding ribosomal proteins and elongation factors. Concurrently, the phosphorylation of 4E-BP1 causes it to dissociate from eukaryotic translation initiation factor 4E (eIF4E), allowing eIF4E to assemble into the active eIF4F translation initiation complex. The net result of these coordinated events is a massive upregulation in the synthesis of new structural muscle proteins.
### Synergism with Mechanical Loading and the Anabolic Window Chemi Nutra's research and subsequent patent (US Patent 10,869,843) highlight that PA significantly enhances mTOR signaling specifically when accompanied by resistance exercise. Mechanical loading primes the muscle cell, making it highly receptive to anabolic signals. When oral PA is administered, it acts synergistically with the mechanical stimulus to sustain and amplify muscle protein synthesis. Furthermore, the efficacy of PA is highly dependent on nutrient availability. The patent notes that PA exhibits its most noticeable effects on muscle mass and strength gains when adequate amounts of protein are administered within the anabolic window—the period immediately surrounding a resistance exercise bout when muscle cells are primed for nutrient uptake and protein synthesis.
### Pharmacokinetics and Oral Bioavailability Historically, there was skepticism regarding the oral bioavailability of intact phospholipids and their ability to reach skeletal muscle tissue. However, clinical evaluations of Mediator® PA have demonstrated that specialized compounding (such as the 50P formulation) allows for sufficient absorption and systemic distribution. Upon oral ingestion, PA is incorporated into chylomicrons and transported through the lymphatic system into systemic circulation. It is subsequently taken up by skeletal muscle tissue, where it integrates into the sarcolemma and intracellular membranes, ready to interact with mTOR upon mechanical stimulation. The precise pharmacokinetics dictate that PA should be consumed prior to exercise to ensure peak serum and intramuscular concentrations align with the mechanical loading stimulus.
What is Phosphatidic Acid? +
How does PA build muscle? +
What is Mediator® PA? +
Is generic PA as effective as Mediator®? +
What is the recommended dose of PA? +
Do I need to work out for PA to work? +
Can women take Phosphatidic Acid? +
Does PA help with fat loss? +
Is Phosphatidic Acid a steroid? +
What is the mTOR pathway? +
When should I take Phosphatidic Acid? +
Can I take PA with creatine? +
Does PA occur naturally in food? +
What is the anabolic window? +
Are there any side effects of PA? +
How long does it take to see results from PA? +
Does PA prevent muscle breakdown? +
Everything About Phosphatidic Acid Article
## Introduction to Phosphatidic Acid For decades, sports nutrition scientists have searched for natural compounds that can safely and effectively accelerate muscle growth and strength gains. While protein and creatine have long been the gold standards, a groundbreaking lipid messenger known as Phosphatidic Acid (PA) has emerged as one of the most exciting discoveries in muscle physiology. Naturally found in very small concentrations in human muscle tissue, PA is a specialized phospholipid that acts as a direct signaling molecule in the body. Its primary function? Telling your muscles to grow.
Due to its limited presence in whole foods and the body's restricted ability to synthesize it in large amounts, researchers began investigating the effects of oral PA supplementation. The results have been nothing short of revolutionary, leading to the development of patented, highly bioavailable forms of PA that are transforming the sports nutrition landscape.
## The Discovery of Mediator® PA The commercialization and clinical validation of Phosphatidic Acid are largely credited to Chemi Nutra, a specialty nutraceutical company based in Milan, Italy, with operations in the United States. Recognizing the immense potential of PA, Chemi Nutra invested considerable time and resources into discovering how this lipid influences load-induced skeletal muscle growth.
Their extensive investigation led to the creation of Mediator® 50P Phosphatidic Acid, the "Original PA." Mediator® is the only PA compound that has been clinically evaluated for both efficacy and safety. On December 22, 2020, Chemi Nutra proudly announced that they had been granted a landmark patent (United States Patent 10,869,843) for Mediator® PA. The patent claims that when consumed orally, and in the absence of creatine, Mediator® PA can significantly increase muscle mass and strength when accompanied by resistance exercise.
## How Phosphatidic Acid Works: The mTOR Pathway To understand why Phosphatidic Acid is so effective, you must understand the mechanistic target of rapamycin (mTOR). mTOR is the master regulatory pathway in the human body responsible for muscle protein synthesis (MPS)—the biological process of building new skeletal muscle.
When you lift weights, the mechanical loading and stress placed on your muscle fibers activate an enzyme called phospholipase D (PLD). PLD then produces endogenous phosphatidic acid. This naturally produced PA binds directly to the mTOR complex, turning on the "ignition switch" for muscle growth.
However, the body's natural production of PA is limited. By supplementing with oral Mediator® PA, you bypass this rate-limiting step. The exogenous PA enters the muscle cell, binds to the mTOR pathway, and significantly enhances and sustains the anabolic signal. This means that the mechanical stress of your workout yields a much higher rate of muscle protein synthesis than it would without supplementation.
## Clinical Evidence and Patent Claims The science behind Mediator® PA is robust and continually emerging. Human clinical studies have demonstrated its incredible ability to accelerate muscle mass and strength gains faster than traditional training alone. In double-blind, placebo-controlled trials, resistance-trained men supplementing with Mediator® PA experienced significantly greater increases in lean body mass, muscle thickness, and 1-rep max strength compared to those taking a placebo.
Furthermore, the research indicates that PA is highly effective at promoting fat mass loss and preserving precious, hard-earned muscle tissue. This makes it an invaluable tool not only for bodybuilders in a bulking phase but also for athletes looking to maintain muscle while cutting body fat.
## Dosing and The Anabolic Window Timing and nutrition play a crucial role in maximizing the benefits of Phosphatidic Acid. Chemi Nutra's research discovered that PA exhibits its most noticeable effects on muscle mass and strength when adequate amounts of protein are administered within the "anabolic window"—the period surrounding a resistance exercise bout.
Because PA acts as the signaling trigger for mTOR, the body still requires the raw building blocks (amino acids from protein) to actually construct the new muscle tissue. Therefore, taking PA pre-workout and following up with a high-quality whey protein or essential amino acid (EAA) supplement post-workout creates the ultimate synergistic environment for hypertrophy.
The clinically validated dose of Mediator® PA is typically 750mg per day, taken roughly one hour before resistance training. While some multi-ingredient pre-workouts or muscle builders may include lower doses (such as 125mg) as part of a broader matrix, the 750mg threshold is where the most profound clinical results have been observed.
## Generic vs. Branded PA: Why It Matters In the supplement industry, the success of a patented ingredient often leads to cheap, generic knock-offs. However, Chemi Nutra has drawn a hard line regarding Phosphatidic Acid. Their US Patent (10,869,843) applies exclusively to their specially compounded Mediator® 50P Phosphatidic Acid.
Chemi Nutra explicitly states that if any other generic PA is used in a nutritional supplement making claims for muscle and strength gains, it constitutes patent infringement. More importantly for the consumer, generic PA extracts (often cheap soy lecithin derivatives) are not standardized for the active PA content required to stimulate mTOR, nor have they been clinically evaluated for safety and efficacy. To ensure you are getting the real, muscle-building ingredient, always look for the Mediator® trademark on the supplement facts panel.